A

American Healthcare REIT Inc
NYSE:AHRT

Watchlist Manager
American Healthcare REIT Inc
NYSE:AHRT
Watchlist
Price: 5.615 USD -11.71% Market Closed
Market Cap: $1.1B

American Healthcare REIT Inc
Investor Relations

American Healthcare REIT Inc. is a fascinating player in the dynamic field of healthcare-focused real estate investment trusts (REITs). At its core, the company capitalizes on the robust demand for healthcare facilities, driven by an aging population and an ever-evolving medical industry. The REIT primarily invests in senior housing, skilled nursing facilities, medical office buildings, and hospitals, which are high-demand sectors within the healthcare market. By acquiring, leasing, and managing these crucial infrastructures, American Healthcare REIT provides essential services to healthcare operators while ensuring a steady influx of rentals and lease agreements.

This strategy of acquiring diversified healthcare properties enables the company to generate a dependable stream of income, distributing earnings to its investors in the form of dividends—a hallmark of REITs. The company meticulously selects its investments, focusing on properties that demonstrate strong underlying healthcare service demand and are often strategically located near major hospitals or healthcare hubs. This positions American Healthcare REIT as not just a landlord, but as a pivotal partner in the provision of healthcare, maintaining assets that are vital to the industry's functioning. By aligning its growth with the medical sector's expansive trends, this REIT continues to weave a narrative of stability and progression within the realm of healthcare infrastructure investment.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 27, 2026
AI Summary
Q4 2025

Strong NOI Growth: American Healthcare REIT delivered total portfolio same-store NOI growth of 11.8% in Q4 and 14.2% for 2025, marking a second consecutive year of double-digit growth.

SHOP Segment Outperformance: The SHOP segment led portfolio growth with Q4 same-store NOI up 24.6% and 2025 growth at 25.2%. Occupancy surpassed 90%.

Trilogy Segment Strength: Trilogy reported Q4 same-store NOI up 14% and 18.4% for the year, with occupancy reaching 90.6% in Q4.

Active Acquisition Year: Over $950 million in new investments were closed in 2025. The SHOP segment is now the second largest by cash NOI.

Double-Digit NFFO Growth: Normalized FFO per share was $0.46 in Q4 and $1.72 for 2025, representing 22% year-over-year growth.

2026 Guidance Raised: 2026 NFFO per share is guided to $1.99–$2.05, with 7–11% total portfolio same-store NOI growth expected.

Balance Sheet Improvement: Net debt-to-EBITDA improved to 3.4x, with ample liquidity and significant unsettled equity agreements.

Leadership Continuity: No change in strategy or capital allocation despite interim CEO transition; leadership affirmed business stability.

Key Financials
Same-Store NOI Growth (Q4 2025)
11.8%
Same-Store NOI Growth (2025 Full Year)
14.2%
SHOP Same-Store NOI Growth (Q4 2025)
24.6%
SHOP Same-Store NOI Growth (2025 Full Year)
25.2%
SHOP Same-Store Occupancy (Q4 2025)
90.6%
Trilogy Same-Store NOI Growth (Q4 2025)
14%
Trilogy Same-Store NOI Growth (2025 Full Year)
18.4%
Trilogy Same-Store Occupancy (Q4 2025)
90.6%
Normalized FFO per Share (Q4 2025)
$0.46
Normalized FFO per Share (2025 Full Year)
$1.72
Net Debt-to-EBITDA
3.4x
Acquisitions Closed (2025)
$950 million
Acquisitions Closed (YTD 2026)
$117.5 million
Acquisitions Pipeline (Awarded Deals)
$230 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Danny Prosky
President, CEO & Director
No Bio Available
Mr. Brian S. Peay
Chief Financial Officer
No Bio Available
Mr. Gabriel M. Willhite
Chief Operating Officer
No Bio Available
Mr. Stefan K. L. Oh
Chief Investment Officer
No Bio Available
Mr. Mark E. Foster
Executive VP, General Counsel & Secretary
No Bio Available
Mr. Kenny Lin
Executive VP, Deputy CFO & Chief Accounting Officer
No Bio Available
Mr. Alan Robert Peterson III
Vice President of Investor Relations & Finance
No Bio Available
Ms. Cora Lo Esq., J.D.
Senior VP, Associate General Counsel & Assistant Secretary
No Bio Available
Mr. Ray Oborn
Executive Vice President of Asset Management
No Bio Available

Contacts

Address
CALIFORNIA
Irvine
18191 Von Karman Avenue, Third Floor
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett